Table 3.

IgM/IgG profile by sociodemographic and clinical characteristics.

Variables	Total (N)	IgM+&IgG+ n(%)	p-Value	IgM+&IgG− n(%)	p-Value	IgM−&IgG+ n(%)	p-Value
Age range (year)
[18–21]	81	8 (9.88)	Ref	4 (4.94)	Ref	13 (16.05)	Ref
[21–24]	120	16 (13.33)	0.26	11 (9.17)	0.5	13 (10.83)	0.31
[24–28]	90	10 (11.11)	0.61	11 (12.22)	0.21	11 (12.22)	0.63
Gender
Female	153	24 (15.69)	Ref	12 (7.84)	Ref	19 (12.42)	Ref
Male	138	10 (7.25)	0.01	14 (10.14)	0.77	18 (13.04)	0.92
Location
Bangangte	198	28 (14.14)	Ref	21 (10.61)		23 (11.62 %)	Ref
Yaounde	93	6 (4.45)	0.05	5 (5.38)	0.11	14 (15.05 %)	0.74
Clinical status
Asymptomatic	234	30 (12.82)	Ref	21 (8.97)	Ref	28 (11.97)	Ref
Symptomatic	57	4 (7.02)	0.15	5 (8.77)	0.67	9 (15.79)	0.6
Comorbidities
No	279	34 (12.19)	Ref	23 (8.24)	Ref	34 (12.19)	Ref
Yes	12	0 (0.00)	0.97	3 (25.00)	0.12	3 (25.00)	0.11
Case-contact
No	235	30 (12.77)	Ref	19 (8.09)	Ref	32 (13.62)	Ref
Yes	56	4 (7.14)	0.05	7 (12.50)	0.9	5 (8.93)	0.18
Nomad
No	271	30 (11.07)	Ref	23 (8.49)	Ref	34 (12.55)	Ref
Yes	20	4 (20.00)	0.01	3 (15.00)	0.3	3 (15.00)	0.21
Treatment
No	287	33 (11.50)	Ref	25 (8.71)	Ref	37 (12.89)	Ref
Yes	4	1 (25.00)	0.22	1 (25.00)	0.2	0 (0.00)	0.98